\-\ Texto\\:\\ \ \(0\)\
\-\ vitals\\:\\ \\ temp\\ 36\\.4\\,\\ hr\\ 64\\,\\ bp\\ 103\\/55\\,\\ rr\\ 18\ \(0\)\
\-\ there\\ was\\ marked\\ proptosis\\ and\\ lagophthalmos\\ bilaterally\\ with\\ injection\\ of\\ the\\ sclera\\ and\\ conjunctiva\\ of\\ the\\ right\\ eye\\.\\ \\ left\\ lid\\ was\\ ptotic\\.\\ heart\\ exam\\ revealed\\ a\\ regular\\ rate\\ and\\ rhythm\\.\\ \\ there\\ was\\ 2\\+\\ pitting\\ edema\\ of\\ the\\ lower\\ extremities\\ bilaterally\\.\ \(0\)\
\-\ the\\ patient\\ was\\ taken\\ to\\ surgery\\ based\\ on\\ outside\\ imaging\\ studies\\ that\\ were\\ not\\ reviewed\\ by\\ our\\ institution\\â\\€\\™s\\ radiologists\\.\\ \\ the\\ surgery\\ failed\\ to\\ improve\\ the\\ patient\\â\\€\\™s\\ ocular\\ symptoms\\,\\ and\\ three\\ weeks\\ later\\ the\\ patient\\ underwent\\ imaging\\ studies\\ at\\ our\\ institution\\,\\ which\\ are\\ displayed\\ in\\ this\\ case\\.\\ \\ \ \(0\)\
\-\ when\\ the\\ imaging\\ findings\\ reviewed\\ by\\ the\\ neuroradiologists\\ strongly\\ suggested\\ metastatic\\ disease\\ greater\\ than\\ thyroid\\ disease\\,\\ the\\ patient\\ was\\ taken\\ back\\ to\\ the\\ operating\\ room\\ and\\ a\\ biopsy\\ of\\ his\\ right\\ lateral\\ rectus\\ muscle\\ was\\ obtained\\.\\ \\ \ \(0\)\
\-\ pathology\\ confirmed\\ poorly\\ differentiated\\ prostate\\ adenocarcinoma\\.\\ \\ \ \(0\)\
\-\ the\\ patient\\ was\\ offered\\ radiation\\ therapy\\ to\\ the\\ orbits\\ but\\ he\\ declined\\.\\ \\ approximately\\ 6\\ months\\ later\\ he\\ suffered\\ total\\ vision\\ loss\\ bilaterally\\.\ \(0\)\
\-\ \\Â\\»\\ ct\\:\\ severe\\ bilateral\\ exophthalmos\\ is\\ noted\\.\\ \\ there\\ is\\ enlargement\\ of\\ the\\ medial\\ rectus\\ muscles\\ bilaterally\\,\\ the\\ right\\ lateral\\ rectus\\,\\ and\\ the\\ left\\ superior\\ rectus\\.\\ \\ the\\ lamina\\ papyracea\\ is\\ disrupted\\ bilaterally\\ with\\ herniation\\ of\\ the\\ medial\\ rectus\\ muscles\\.\\ \\ the\\ optic\\ nerves\\ are\\ compressed\\ bilaterally\\ by\\ the\\ extraocular\\ muscles\\.\ \(0\)\
\-\ \\Â\\»\\ mr\\:\\ again\\ seen\\ is\\ the\\ enlargement\\ of\\ the\\ bilateral\\ medial\\ rectus\\ muscles\\,\\ left\\ superior\\ rectus\\,\\ and\\ right\\ lateral\\ rectus\\.\\ \\ the\\ inferior\\ rectus\\ muscles\\ are\\ spared\\ bilaterally\\.\\ \\ the\\ enlarged\\ muscles\\ demonstrate\\ both\\ enhancement\\ and\\ restricted\\ diffusion\\.\\ \\ the\\ optic\\ nerves\\ are\\ compressed\\ bilaterally\\.\ \(0\)\
\-\ prostate\\ cancer\\ metastases\\,\\ orbit\\,\\ extraocular\\ muscles\ \(0\)\
\-\ \\â\\€\\¢\\ thyroid\\-associated\\ orbitopathy\ \(0\)\
\-\ \\â\\€\\¢\\ metastases\\ to\\ eoms\ \(0\)\
\-\ \\â\\€\\¢\\ idiopathic\\ orbital\\ pseudotumor\ \(0\)\
\-\ \\â\\€\\¢\\ sarcoidosis\ \(1\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ an\\ 84\\ year\\-old\\ man\\ presented\\ with\\ several\\ weeks\\ of\\ decreased\\ vision\\,\\ diplopia\\,\\ and\\ proptosis\\.\\ \\ review\\ of\\ systems\\ was\\ unremarkable\\.\\ \\ his\\ past\\ medical\\ history\\ was\\ significant\\ for\\ prostate\\ cancer\\ status\\ post\\ xrt\\ for\\ bone\\ metastases\\.\\ \\ the\\ patient\\ underwent\\ bilateral\\ orbital\\ decompression\\ surgery\\ for\\ his\\ ocular\\ symptoms\\ based\\ on\\ outside\\ images\\ not\\ reviewed\\ at\\ our\\ institution\\.\ \(0\)\
\-\ this\\ case\\ illustrates\\ the\\ importance\\ of\\ assessing\\ the\\ pattern\\ of\\ extraocular\\ muscle\\ involvement\\.\\ \\ the\\ patient\\â\\€\\™s\\ presentation\\ is\\ suggestive\\ of\\ thyroid\\-associated\\ orbitopathy\\.\\ \\ however\\,\\ the\\ imaging\\ does\\ not\\ support\\ this\\ diagnosis\\.\\ \\ the\\ inferior\\ rectus\\ muscles\\ are\\ spared\\,\\ as\\ is\\ the\\ left\\ lateral\\ rectus\\ muscle\\.\\ \\ thyroid\\-associated\\ orbitopathy\\ is\\ typically\\ characterized\\ by\\ bilateral\\ and\\ more\\ symmetric\\ muscle\\ involvement\\.\\ \\ the\\ inferior\\ muscle\\ group\\ is\\ involved\\ most\\ commonly\\,\\ followed\\ by\\ \\(in\\ decreasing\\ order\\ of\\ frequency\\)\\ medial\\,\\ superior\\,\\ and\\ lateral\\ rectus\\ muscles\\.\\ \\ additionally\\,\\ the\\ muscle\\ tendons\\ are\\ usually\\ spared\\ \\-\\ in\\ distinction\\ from\\ orbital\\ pseudotumor\\ and\\ lymphoma\\.\ \(0\)\
\-\ metastases\\ to\\ the\\ extraocular\\ muscles\\ are\\ a\\ rare\\ occurrence\\,\\ comprising\\ only\\ 9\\%\\ of\\ all\\ cases\\ of\\ orbital\\ metastases\\.\\ \\ the\\ most\\ common\\ primary\\ malignancies\\ are\\ breast\\ and\\ cutaneous\\ melanoma\\.\\ \\ one\\ study\\ reports\\ the\\ order\\ of\\ most\\ commonly\\ involved\\ muscles\\,\\ in\\ decreasing\\ frequency\\,\\ as\\ medial\\ \\(39\\%\\)\\,\\ lateral\\ \\(33\\%\\)\\,\\ superior\\ \\(16\\%\\)\\,\\ and\\ inferior\\ \\(12\\%\\)\\.\\ \\ cases\\ of\\ unilateral\\,\\ asymmetric\\ extraocular\\ muscle\\ disease\\ far\\ outnumbered\\ those\\ of\\ bilateral\\,\\ symmetric\\ disease\\ as\\ seen\\ in\\ thyroid\\-associated\\ orbitopathy\\.\ \(0\)\
\-\ references\\:\\ \ \(0\)\
\-\ lacey\\ b\\,\\ chang\\ w\\,\\ rootman\\ j\\.\\ \\ nonthyroid\\ causes\\ of\\ extraocular\\ muscle\\ disease\\.\\ \\ surv\\ ophthalmol\\ 1999\\;\\ 44\\:187\\â\\€\\“213\\.\ \(0\)\
\-\ goldberg\\ ra\\,\\ rootman\\ j\\,\\ cline\\ ra\\.\\ \\ tumors\\ metastatic\\ to\\ the\\ orbit\\:\\ a\\ changing\\ picture\\.\\ surv\\ ophthalmol\\ 1990\\;\\ 35\\:1\\-24\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ rectus\\:\\ 0\\.09616176492172333\ \(0\)\
\-\ muscles\\:\\ 0\\.06958103552760926\ \(0\)\
\-\ thyroid\\-associated\\:\\ 0\\.05715084877774067\ \(0\)\
\-\ extraocular\\:\\ 0\\.0508784390811383\ \(0\)\
\-\ orbitopathy\\:\\ 0\\.045534904082583094\ \(0\)\
\-\ muscle\\:\\ 0\\.03979663187586833\ \(0\)\
\-\ bilaterally\\:\\ 0\\.0363916400456908\ \(0\)\
\-\ metastases\\:\\ 0\\.029584541734546062\ \(0\)\
\-\ surv\\:\\ 0\\.028575424388870334\ \(0\)\
\-\ spared\\:\\ 0\\.028297177392605385\ \(0\)\
\-\ reviewed\\:\\ 0\\.02761762175706977\ \(0\)\
\-\ orbital\\:\\ 0\\.02627776005944079\ \(0\)\
\-\ rootman\\:\\ 0\\.025014282448292992\ \(0\)\
\-\ ophthalmol\\:\\ 0\\.024081763574867448\ \(0\)\
\-\ institution\\:\\ 0\\.022641662920292512\ \(0\)\
\-\ medial\\:\\ 0\\.022149915020989074\ \(0\)\
\-\ prostate\\:\\ 0\\.022068973930066987\ \(0\)\
\-\ our\\:\\ 0\\.019750056237569535\ \(0\)\
\-\ inferior\\:\\ 0\\.01879621628109603\ \(0\)\
\-\ lateral\\:\\ 0\\.01795787402552237\ \(0\)\
\-\ superior\\:\\ 0\\.01769039673941129\ \(0\)\
\-\ decreasing\\:\\ 0\\.01766036497238257\ \(0\)\
\-\ compressed\\:\\ 0\\.0168706661631192\ \(0\)\
\-\ bilateral\\:\\ 0\\.016805654208382852\ \(0\)\
\-\ ocular\\:\\ 0\\.01678422127792581\ \(0\)\
\-\ \\%\\:\\ 0\\.016153330902317728\ \(0\)\
\-\ pseudotumor\\:\\ 0\\.01602696082028722\ \(0\)\
\-\ proptosis\\:\\ 0\\.015469909744349912\ \(0\)\
\-\ ra\\:\\ 0\\.01514549010559146\ \(0\)\
\-\ are\\:\\ 0\\.015103713096007802\ \(0\)\
\-\ frequency\\:\\ 0\\.014623835756117757\ \(0\)\
\-\ was\\:\\ 0\\.014415717503927361\ \(0\)\
\-\ 103\\/55\\:\\ 0\\.014287712194435167\ \(0\)\
\-\ lagophthalmos\\:\\ 0\\.014287712194435167\ \(0\)\
\-\ neuroradiologists\\:\\ 0\\.014287712194435167\ \(0\)\
\-\ outnumbered\\:\\ 0\\.014287712194435167\ \(0\)\
\-\ lacey\\:\\ 0\\.014287712194435167\ \(0\)\
\-\ nonthyroid\\:\\ 0\\.014287712194435167\ \(0\)\
\-\ 44\\:187\\â\\€\\“213\\:\\ 0\\.014287712194435167\ \(0\)\
\-\ cline\\:\\ 0\\.014287712194435167\ \(0\)\
\-\ 35\\:1\\-24\\:\\ 0\\.014287712194435167\ \(0\)\
\-\ nerves\\:\\ 0\\.014062177016169502\ \(0\)\
\-\ \\,\\:\\ 0\\.014040068227800965\ \(0\)\
\-\ orbit\\:\\ 0\\.013953513508750886\ \(0\)\
\-\ order\\:\\ 0\\.0138830435358614\ \(0\)\
\-\ \\Â\\»\\:\\ 0\\.013647806281939729\ \(0\)\
\-\ ptotic\\:\\ 0\\.013164296990934445\ \(0\)\
\-\ imaging\\:\\ 0\\.012979408910571167\ \(0\)\
\-\ optic\\:\\ 0\\.01282238580098809\ \(0\)\
\-\ vision\\:\\ 0\\.012797354857409775\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.012698657630436693\ \(0\)\
\-\ symmetric\\:\\ 0\\.012651097368656227\ \(0\)\
\-\ goldberg\\:\\ 0\\.012507141224146496\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.012418282364564617\ \(0\)\
\-\ chang\\:\\ 0\\.012040881787433724\ \(0\)\
\-\ his\\:\\ 0\\.011975149243015877\ \(0\)\
\-\ s\\:\\ 0\\.011916212319844022\ \(0\)\
\-\ eoms\\:\\ 0\\.011679222871203238\ \(0\)\
\-\ outside\\:\\ 0\\.011618832437964056\ \(0\)\
\-\ involved\\:\\ 0\\.011618832437964056\ \(0\)\
\-\ taken\\:\\ 0\\.011550226891150303\ \(0\)\
\-\ by\\:\\ 0\\.011530558373135127\ \(0\)\
\-\ papyracea\\:\\ 0\\.011383726020645774\ \(0\)\
\-\ disease\\:\\ 0\\.011318780722979774\ \(0\)\
\-\ 36\\.4\\:\\ 0\\.01113388699337307\ \(0\)\
\-\ pitting\\:\\ 0\\.01113388699337307\ \(0\)\
\-\ enlargement\\:\\ 0\\.010990497265753955\ \(0\)\
\-\ based\\:\\ 0\\.010563015760995009\ \(0\)\
\-\ comprising\\:\\ 0\\.010555807667702515\ \(0\)\
\-\ commonly\\:\\ 0\\.010452289930164152\ \(0\)\
\-\ conjunctiva\\:\\ 0\\.010401334118586916\ \(0\)\
\-\ studies\\:\\ 0\\.010345221775621263\ \(0\)\
\-\ distinction\\:\\ 0\\.010260310817145053\ \(0\)\
\-\ involvement\\:\\ 0\\.010152151237043164\ \(0\)\
\-\ exophthalmos\\:\\ 0\\.010130581955437538\ \(0\)\
\-\ surgery\\:\\ 0\\.010089136455560494\ \(0\)\
\-\ lid\\:\\ 0\\.010010471789872348\ \(0\)\
\-\ later\\:\\ 0\\.010001357021046754\ \(0\)\
\-\ lamina\\:\\ 0\\.009898651900914567\ \(0\)\
\-\ changing\\:\\ 0\\.009898651900914567\ \(0\)\
\-\ patient\\:\\ 0\\.009718222879116233\ \(0\)\
\-\ most\\:\\ 0\\.009592391288791295\ \(0\)\
\-\ sclera\\:\\ 0\\.009515525842463627\ \(0\)\
\-\ radiologists\\:\\ 0\\.009515525842463627\ \(0\)\
\-\ declined\\:\\ 0\\.009515525842463627\ \(0\)\
\-\ underwent\\:\\ 0\\.009504687311112541\ \(0\)\
\-\ offered\\:\\ 0\\.009432392464201795\ \(0\)\
\-\ xrt\\:\\ 0\\.009432392464201795\ \(0\)\
\-\ assessing\\:\\ 0\\.009432392464201795\ \(0\)\
\-\ displayed\\:\\ 0\\.0093533160230844\ \(0\)\
\-\ disrupted\\:\\ 0\\.0093533160230844\ \(0\)\
\-\ 1990\\:\\ 0\\.009277918915086194\ \(0\)\
\-\ cases\\:\\ 0\\.009227912038836734\ \(0\)\
\-\ \\:\\:\\ 0\\.009159439351626135\ \(0\)\
\-\ w\\:\\ 0\\.00913689561364433\ \(0\)\
\-\ cancer\\:\\ 0\\.009105884163256937\ \(0\)\
\-\ occurrence\\:\\ 0\\.009070733547971308\ \(0\)\
\-\ orbits\\:\\ 0\\.009007166751936815\ \(0\)\
\-\ malignancies\\:\\ 0\\.008830182486191286\ \(0\)\
\-\ operating\\:\\ 0\\.00872209273821937\ \(0\)\
\-\ 84\\:\\ 0\\.00872209273821937\ \(0\)\
\-\ suffered\\:\\ 0\\.008620763148298245\ \(0\)\
\-\ the\\:\\ 0\\.008514542655976953\ \(0\)\
\-\ tendons\\:\\ 0\\.0084353330815596\ \(0\)\
\-\ illustrates\\:\\ 0\\.008392110638962905\ \(0\)\
\-\ j\\.\\:\\ 0\\.008154503711585473\ \(0\)\
\-\ picture\\:\\ 0\\.008118080930625897\ \(0\)\
\-\ diplopia\\:\\ 0\\.008082458715522533\ \(0\)\
\-\ importance\\:\\ 0\\.008082458715522533\ \(0\)\
\-\ cutaneous\\:\\ 0\\.008047602629264895\ \(0\)\
\-\ lymphoma\\:\\ 0\\.007916365103369483\ \(0\)\
\-\ weeks\\:\\ 0\\.00786151622982544\ \(0\)\
\-\ 1999\\:\\ 0\\.007852879271336105\ \(0\)\
\-\ far\\:\\ 0\\.007822584080068433\ \(0\)\
\-\ failed\\:\\ 0\\.007734954872174956\ \(0\)\
\-\ he\\:\\ 0\\.007728322016314487\ \(0\)\
\-\ strongly\\:\\ 0\\.007706767282690566\ \(0\)\
\-\ temp\\:\\ 0\\.007679061556014228\ \(0\)\
\-\ 64\\:\\ 0\\.007547220973430836\ \(0\)\
\-\ support\\:\\ 0\\.007425302948734584\ \(0\)\
\-\ differentiated\\:\\ 0\\.0074019824666404195\ \(0\)\
\-\ improve\\:\\ 0\\.007378992782698837\ \(0\)\
\-\ systems\\:\\ 0\\.007356324643355661\ \(0\)\
\-\ decompression\\:\\ 0\\.0073339691779872075\ \(0\)\
\-\ is\\:\\ 0\\.0072906421832703485\ \(0\)\
\-\ group\\:\\ 0\\.007205949062397855\ \(0\)\
\-\ rhythm\\:\\ 0\\.00718556205720035\ \(0\)\
\-\ 33\\:\\ 0\\.00718556205720035\ \(0\)\
\-\ 2\\+\\:\\ 0\\.0070873049715983495\ \(0\)\
\-\ rr\\:\\ 0\\.007068348667281993\ \(0\)\
\-\ melanoma\\:\\ 0\\.007068348667281993\ \(0\)\
\-\ suggested\\:\\ 0\\.0070496115159026165\ \(0\)\
\-\ metastatic\\:\\ 0\\.006972801956616176\ \(0\)\
\-\ symptoms\\:\\ 0\\.006903265727384567\ \(0\)\
\-\ characterized\\:\\ 0\\.0068900652066428885\ \(0\)\
\-\ unilateral\\:\\ 0\\.006873269765742488\ \(0\)\
\-\ poorly\\:\\ 0\\.006760336344935374\ \(0\)\
\-\ hr\\:\\ 0\\.006744826699852472\ \(0\)\
\-\ asymmetric\\:\\ 0\\.006729464067835383\ \(0\)\
\-\ again\\:\\ 0\\.006654762111270931\ \(0\)\
\-\ vitals\\:\\ 0\\.006625819457462168\ \(0\)\
\-\ \\;\\:\\ 0\\.006565384727561081\ \(0\)\
\-\ b\\:\\ 0\\.006528406290412402\ \(0\)\
\-\ injection\\:\\ 0\\.00646224422473938\ \(0\)\
\-\ 39\\:\\ 0\\.006436517564842637\ \(0\)\
\-\ regular\\:\\ 0\\.006386257861856315\ \(0\)\
\-\ restricted\\:\\ 0\\.006373932741296802\ \(0\)\
\-\ idiopathic\\:\\ 0\\.006313675037501415\ \(0\)\
\-\ those\\:\\ 0\\.006301887745233863\ \(0\)\
\-\ as\\:\\ 0\\.006284817694785063\ \(0\)\
\-\ 16\\:\\ 0\\.006267031658976224\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.006255577579198116\ \(0\)\
\-\ j\\:\\ 0\\.006255577579198116\ \(0\)\
\-\ diffusion\\:\\ 0\\.006199490822022304\ \(0\)\
\-\ left\\:\\ 0\\.006198413415059415\ \(0\)\
\-\ there\\:\\ 0\\.006183381960121501\ \(0\)\
\-\ herniation\\:\\ 0\\.006166747374181916\ \(0\)\
\-\ case\\:\\ 0\\.006059981954188884\ \(0\)\
\-\ bp\\:\\ 0\\.006012273825066317\ \(0\)\
\-\ 18\\:\\ 0\\.006012273825066317\ \(0\)\
\-\ not\\:\\ 0\\.006003980575730643\ \(0\)\
\-\ review\\:\\ 0\\.0060024807708427145\ \(0\)\
\-\ additionally\\:\\ 0\\.0060024807708427145\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.005983070412582235\ \(0\)\
\-\ total\\:\\ 0\\.005963889768097627\ \(0\)\
\-\ room\\:\\ 0\\.005954383901886285\ \(0\)\
\-\ suggestive\\:\\ 0\\.0059169083469092125\ \(0\)\
\-\ \\(\\:\\ 0\\.005853822741036146\ \(0\)\
\-\ right\\:\\ 0\\.005845262295691518\ \(0\)\
\-\ eye\\:\\ 0\\.005809416218982028\ \(0\)\
\-\ \\)\\:\\ 0\\.005782315171096475\ \(0\)\
\-\ references\\:\\ 0\\.00575823052684216\ \(0\)\
\-\ 9\\:\\ 0\\.005724983298587536\ \(0\)\
\-\ thyroid\\:\\ 0\\.00567635728512919\ \(0\)\
\-\ pathology\\:\\ 0\\.005668392917540165\ \(0\)\
\-\ 12\\:\\ 0\\.005668392917540165\ \(0\)\
\-\ reports\\:\\ 0\\.005583274547550787\ \(0\)\
\-\ seen\\:\\ 0\\.005473671361645673\ \(0\)\
\-\ extremities\\:\\ 0\\.005432231149012785\ \(0\)\
\-\ marked\\:\\ 0\\.00540499108691168\ \(0\)\
\-\ rate\\:\\ 0\\.005398252010495694\ \(0\)\
\-\ causes\\:\\ 0\\.005391540839237944\ \(0\)\
\-\ rare\\:\\ 0\\.0053782012944461844\ \(0\)\
\-\ pattern\\:\\ 0\\.005294071862352152\ \(0\)\
\-\ confirmed\\:\\ 0\\.005208103084419444\ \(0\)\
\-\ greater\\:\\ 0\\.005202133480827392\ \(0\)\
\-\ tumors\\:\\ 0\\.005202133480827392\ \(0\)\
\-\ breast\\:\\ 0\\.0051094942363542175\ \(0\)\
\-\ year\\-old\\:\\ 0\\.005087138770985764\ \(0\)\
\-\ status\\:\\ 0\\.004943804410343036\ \(0\)\
\-\ obtained\\:\\ 0\\.004923607942858739\ \(0\)\
\-\ biopsy\\:\\ 0\\.00491360330897368\ \(0\)\
\-\ typically\\:\\ 0\\.004888858621565595\ \(0\)\
\-\ to\\:\\ 0\\.004845181133064674\ \(0\)\
\-\ heart\\:\\ 0\\.004812122607631725\ \(0\)\
\-\ presentation\\:\\ 0\\.004770503459466908\ \(0\)\
\-\ enlarged\\:\\ 0\\.004725479854755277\ \(0\)\
\-\ does\\:\\ 0\\.004725479854755277\ \(0\)\
\-\ this\\:\\ 0\\.004673276563926093\ \(0\)\
\-\ three\\:\\ 0\\.004668758879006338\ \(0\)\
\-\ followed\\:\\ 0\\.004643234799641445\ \(0\)\
\-\ unremarkable\\:\\ 0\\.0045851967887877805\ \(0\)\
\-\ back\\:\\ 0\\.004568989198294128\ \(0\)\
\-\ study\\:\\ 0\\.004556938990048556\ \(0\)\
\-\ radiation\\:\\ 0\\.0045449777140394425\ \(0\)\
\-\ several\\:\\ 0\\.004452338469566268\ \(0\)\
\-\ revealed\\:\\ 0\\.004444852333656553\ \(0\)\
\-\ mr\\:\\ 0\\.004400647442376717\ \(0\)\
\-\ past\\:\\ 0\\.004400647442376717\ \(0\)\
\-\ post\\:\\ 0\\.004361158886664981\ \(0\)\
\-\ approximately\\:\\ 0\\.004284955958761074\ \(0\)\
\-\ severe\\:\\ 0\\.004261442139491092\ \(0\)\
\-\ medical\\:\\ 0\\.004261442139491092\ \(0\)\
\-\ usually\\:\\ 0\\.004205718401728945\ \(0\)\
\-\ only\\:\\ 0\\.004164362493492602\ \(0\)\
\-\ 6\\:\\ 0\\.0041363373766205415\ \(0\)\
\-\ decreased\\:\\ 0\\.0041179196154368875\ \(0\)\
\-\ primary\\:\\ 0\\.0041027297615813555\ \(0\)\
\-\ and\\:\\ 0\\.004084483112238344\ \(0\)\
\-\ loss\\:\\ 0\\.004020201251974781\ \(0\)\
\-\ when\\:\\ 0\\.003966501195487853\ \(0\)\
\-\ edema\\:\\ 0\\.003917217973146338\ \(0\)\
\-\ all\\:\\ 0\\.003917217973146338\ \(0\)\
\-\ however\\:\\ 0\\.003856350171145981\ \(0\)\
\-\ months\\:\\ 0\\.0037827249508753115\ \(0\)\
\-\ presented\\:\\ 0\\.003775296004898556\ \(0\)\
\-\ one\\:\\ 0\\.003753211318169601\ \(0\)\
\-\ at\\:\\ 0\\.0037528789394866546\ \(0\)\
\-\ significant\\:\\ 0\\.003724225528450929\ \(0\)\
\-\ enhancement\\:\\ 0\\.0037122994588703983\ \(0\)\
\-\ therapy\\:\\ 0\\.003702821387748157\ \(0\)\
\-\ than\\:\\ 0\\.0036289284520555493\ \(0\)\
\-\ common\\:\\ 0\\.0036244201166230096\ \(0\)\
\-\ of\\:\\ 0\\.003587637301720875\ \(0\)\
\-\ for\\:\\ 0\\.0035450963467230884\ \(0\)\
\-\ both\\:\\ 0\\.003536790908729532\ \(0\)\
\-\ more\\:\\ 0\\.0034638189778155044\ \(0\)\
\-\ bone\\:\\ 0\\.0034415472957210207\ \(0\)\
\-\ in\\:\\ 0\\.0034148884128059557\ \(0\)\
\-\ noted\\:\\ 0\\.0032826923637805407\ \(0\)\
\-\ man\\:\\ 0\\.0032754162772933534\ \(0\)\
\-\ demonstrate\\:\\ 0\\.003187118543489531\ \(0\)\
\-\ diagnosis\\:\\ 0\\.00318025823465222\ \(0\)\
\-\ were\\:\\ 0\\.003144710432236501\ \(0\)\
\-\ lower\\:\\ 0\\.0031148493830856767\ \(0\)\
\-\ exam\\:\\ 0\\.0030425185412472256\ \(0\)\
\-\ \\-\\:\\ 0\\.002968765735345808\ \(0\)\
\-\ but\\:\\ 0\\.002953814102161325\ \(0\)\
\-\ findings\\:\\ 0\\.00294787185703397\ \(0\)\
\-\ images\\:\\ 0\\.0026568296465953874\ \(0\)\
\-\ which\\:\\ 0\\.0025853234801337904\ \(0\)\
\-\ a\\:\\ 0\\.0025711494445290195\ \(0\)\
\-\ that\\:\\ 0\\.002392189187291448\ \(0\)\
\-\ on\\:\\ 0\\.0023464862637453095\ \(0\)\
\-\ \\.\\:\\ 0\\.0021863571664492033\ \(0\)\
\-\ from\\:\\ 0\\.002052570037527086\ \(0\)\
\-\ ct\\:\\ 0\\.0019372830687067145\ \(0\)\
\-\ an\\:\\ 0\\.0019151780620498052\ \(0\)\
\-\ history\\:\\ 0\\.0019128274517132631\ \(0\)\
\-\ with\\:\\ 0\\.000568901990712592\ \(0\)\
